Legal
Opened: CBP's $127B Tariff Refund Portal; Walmart Owed $10.2B
Following the Supreme Court's February ruling that invalidated tariffs collected under the International Emergency Economic Powers Act, U.S. Customs and…
Latest — Page 34
Legal
Zaglin Drops New Trial Motion, 8-Year FCPA Sentence Stands
Carl Zaglin, convicted of FCPA violations in the Southern District of Florida, has withdrawn his Second Motion for a New Trial — quietly collapsing a bid…
FDA
Trump EO Cuts Psychedelic Reviews, Compass Jumps 25%
Trump signed an executive order Saturday directing FDA to issue Commissioner's National Priority Vouchers (CNPVs) to psychedelic drugs with breakthrough…
Deals
Kelonia Sale Hands Venrock a 45-Fold Return on $20M
Venrock put $20 million into Kelonia Therapeutics.
FDA
Trump Backs FDA Push to Fast-Track Psychedelic Treatments
Trump has vowed to push FDA to expedite psychedelic drug development.
FDA
Wins Third Phase 3 in COPD: AstraZeneca's Tozorakimab Eyes $5B Peak
Tozorakimab now has three phase 3 COPD wins in 2026.
Deals
Lilly Bets on Kelonia's In Vivo CAR-T
Lilly paid an undisclosed sum upfront for Kelonia Therapeutics on Monday, placing a large bet on in vivo CAR-T as its next platform priority.
FDA
Novo Targets FDA Filing for Etavopivat After 27% VOC Reduction
Etavopivat cut vaso-occlusive crisis rates by 27% in a 385-patient phase 3 trial, and Novo Nordisk is now targeting an FDA submission in the second half of…
Deals
Kailera Raises $625M in Record Biotech IPO on Nasdaq
Kailera Therapeutics raised $625 million Friday in a record-setting biotech IPO on the Nasdaq.
Legal
OCC Hits Federal Savings Bank With Consent Order for Deceptive VA Loan Ads
The OCC issued a consent order against The Federal Savings Bank of Chicago this month, alleging deceptive acts or practices in the bank's advertising to…
Legal
FinCEN Filed NPRM Offering 10-30% Cut to Financial Crime Whistleblowers
FinCEN published a Notice of Proposed Rulemaking under 31 U.S.C. § 5323 that would pay whistleblowers 10-30% of monetary sanctions collected in cases…
Deals
Kraken Paid $550M for Bitnomial's Triple CFTC License Stack
Kraken paid up to $550 million for Bitnomial, a derivatives firm, in a deal that closes by June.
FDA
RevMed Doubles Phase 3 Survival With Pan-RAS Drug at AACR25
Revolution Medicines' pan-RAS inhibitor delivered a landmark Phase 3 survival readout at AACR25 that doubled survival, setting off what the oncology field…
Deals
UCB Paid $1.15B for Neurona's Single-Dose Epilepsy Cell Therapy
UCB paid up to $650m upfront, with up to $500m in future milestones, to buy Neurona Therapeutics in a deal valued at up to $1.15bn.
SEC
OCC Clears JPMorgan's $250M Trade Surveillance Order After 2 Years
$348.2 million later, the OCC decided JPMorgan Chase has done enough.
